Literature DB >> 15634789

Congenital stationary night blindness type 2 mutations S229P, G369D, L1068P, and W1440X alter channel gating or functional expression of Ca(v)1.4 L-type Ca2+ channels.

Jean-Charles Hoda1, Francesca Zaghetto, Alexandra Koschak, Jörg Striessnig.   

Abstract

Mutations in the CACNA1F gene (voltage-dependent L-type calcium channel alpha1F subunit) encoding retinal Ca(v)1.4 L-type Ca2+ channels cause X-linked recessive congenital stationary night blindness type 2 (CSNB2). Many of them are predicted to yield nonfunctional channels. Complete loss of Ca(v)1.4 function is therefore regarded as a pathogenetic mechanism for the impaired signaling from photoreceptors to second-order retinal neurons. We investigated the functional consequences of CSNB2 missense mutations S229P, G369D, and L1068P and the C-terminal truncation mutant W1440X. After expression in Xenopus laevis oocytes or human embryonic kidney tsA-201 cells, inward Ca2+ current (I(Ca)) and inward Ba2+ current (I(Ba)) could be recorded from mutations G369D and L1068P. G369D shifted the half-maximal voltage for channel activation (V(0.5,act)) significantly to more negative potentials (>11 mV), slowed inactivation, and removed Ca2+-dependent inactivation. The L1068P mutant yielded currents only in the presence of the channel activator BayK8644. Currents (I(Ba)) inactivated faster than wild type (WT) and recovered more slowly from inactivation (I(Ba) and I(Ca)). No channel activity could be measured for mutants S229P and W1440X after oocyte expression. No W1440X alpha1 protein was detected after expression in tsA-201 cells, whereas S229P (as well as G369D and L1068P) alpha1 subunits were expressed at levels indistinguishable from WT (n = 3). Our data provide unequivocal evidence that CSNB2 missense mutations can induce severe changes in Ca(v)1.4 function, which may decrease (L1068P and S229P) or even increase (G369D) channel activity. The lower activation range of G369D can explain the reduced dynamic range of photoreceptor signaling. Moreover, we demonstrate that loss of channel function of one (L1068P) CSNB2 mutation can be rescued by a Ca2+ channel activator.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15634789      PMCID: PMC6725195          DOI: 10.1523/JNEUROSCI.3054-04.2005

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  36 in total

1.  Noise and light adaptation in rods of the macaque monkey.

Authors:  D M Schneeweis; J L Schnapf
Journal:  Vis Neurosci       Date:  2000 Sep-Oct       Impact factor: 3.241

Review 2.  Structure and regulation of voltage-gated Ca2+ channels.

Authors:  W A Catterall
Journal:  Annu Rev Cell Dev Biol       Date:  2000       Impact factor: 13.827

Review 3.  Neurotransmitter release at ribbon synapses in the retina.

Authors:  C W Morgans
Journal:  Immunol Cell Biol       Date:  2000-08       Impact factor: 5.126

4.  Clinical variability among patients with incomplete X-linked congenital stationary night blindness and a founder mutation in CACNA1F.

Authors:  K M Boycott; W G Pearce; N T Bech-Hansen
Journal:  Can J Ophthalmol       Date:  2000-06       Impact factor: 1.882

5.  Congenital deafness and sinoatrial node dysfunction in mice lacking class D L-type Ca2+ channels.

Authors:  J Platzer; J Engel; A Schrott-Fischer; K Stephan; S Bova; H Chen; H Zheng; J Striessnig
Journal:  Cell       Date:  2000-07-07       Impact factor: 41.582

6.  Expression of the alpha1F calcium channel subunit by photoreceptors in the rat retina.

Authors:  C W Morgans; P Gaughwin; R Maleszka
Journal:  Mol Vis       Date:  2001-08-22       Impact factor: 2.367

7.  Calcium-activated potassium current clamps the dark potential of vertebrate rods.

Authors:  A Moriondo; B Pelucchi; G Rispoli
Journal:  Eur J Neurosci       Date:  2001-07       Impact factor: 3.386

8.  Delayed cerebral edema and fatal coma after minor head trauma: role of the CACNA1A calcium channel subunit gene and relationship with familial hemiplegic migraine.

Authors:  E E Kors; G M Terwindt; F L Vermeulen; R B Fitzsimons; P E Jardine; P Heywood; S Love; A M van den Maagdenberg; J Haan; R R Frants; M D Ferrari
Journal:  Ann Neurol       Date:  2001-06       Impact factor: 10.422

9.  Antinociceptive action of amlodipine blocking N-type Ca2+ channels at the primary afferent neurons in mice.

Authors:  M Murakami; O Nakagawasai; S Fujii; K Kameyama; S Murakami; S Hozumi; A Esashi; R Taniguchi; T Yanagisawa; K Tan-no; T Tadano; K Kitamura; K Kisara
Journal:  Eur J Pharmacol       Date:  2001-05-11       Impact factor: 4.432

10.  Conserved Ca2+-antagonist-binding properties and putative folding structure of a recombinant high-affinity dihydropyridine-binding domain.

Authors:  I Huber; E Wappl; A Herzog; J Mitterdorfer; H Glossmann; T Langer; J Striessnig
Journal:  Biochem J       Date:  2000-05-01       Impact factor: 3.857

View more
  30 in total

Review 1.  Kinetics of synaptic transmission at ribbon synapses of rods and cones.

Authors:  Wallace B Thoreson
Journal:  Mol Neurobiol       Date:  2007-07-10       Impact factor: 5.590

Review 2.  Voltage-Gated Calcium Channels: Key Players in Sensory Coding in the Retina and the Inner Ear.

Authors:  Tina Pangrsic; Joshua H Singer; Alexandra Koschak
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

Review 3.  Calcium binding protein-mediated regulation of voltage-gated calcium channels linked to human diseases.

Authors:  Nasrin Nejatbakhsh; Zhong-ping Feng
Journal:  Acta Pharmacol Sin       Date:  2011-06       Impact factor: 6.150

4.  X linked cone-rod dystrophy, CORDX3, is caused by a mutation in the CACNA1F gene.

Authors:  R Jalkanen; M Mäntyjärvi; R Tobias; J Isosomppi; E-M Sankila; T Alitalo; N T Bech-Hansen
Journal:  J Med Genet       Date:  2006-02-27       Impact factor: 6.318

5.  Functional impact of a congenital stationary night blindness type 2 mutation depends on subunit composition of Cav1.4 Ca2+ channels.

Authors:  Brittany Williams; Josue A Lopez; J Wesley Maddox; Amy Lee
Journal:  J Biol Chem       Date:  2020-10-08       Impact factor: 5.157

6.  Loss of Ca(v)1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness.

Authors:  Shahid M Baig; Alexandra Koschak; Andreas Lieb; Mathias Gebhart; Claudia Dafinger; Gudrun Nürnberg; Amjad Ali; Ilyas Ahmad; Martina J Sinnegger-Brauns; Niels Brandt; Jutta Engel; Matteo E Mangoni; Muhammad Farooq; Habib U Khan; Peter Nürnberg; Jörg Striessnig; Hanno J Bolz
Journal:  Nat Neurosci       Date:  2010-12-05       Impact factor: 24.884

7.  The nob2 mouse, a null mutation in Cacna1f: anatomical and functional abnormalities in the outer retina and their consequences on ganglion cell visual responses.

Authors:  Bo Chang; John R Heckenlively; Philippa R Bayley; Nicholas C Brecha; Muriel T Davisson; Norm L Hawes; Arlene A Hirano; Ronald E Hurd; Akihiro Ikeda; Britt A Johnson; Maureen A McCall; Catherine W Morgans; Steve Nusinowitz; Neal S Peachey; Dennis S Rice; Kirstan A Vessey; Ronald G Gregg
Journal:  Vis Neurosci       Date:  2006 Jan-Feb       Impact factor: 3.241

8.  Molecular endpoints of Ca2+/calmodulin- and voltage-dependent inactivation of Ca(v)1.3 channels.

Authors:  Michael R Tadross; Manu Ben Johny; David T Yue
Journal:  J Gen Physiol       Date:  2010-02-08       Impact factor: 4.086

9.  A CACNA1F mutation identified in an X-linked retinal disorder shifts the voltage dependence of Cav1.4 channel activation.

Authors:  Ariana Hemara-Wahanui; Stanislav Berjukow; Carolyn I Hope; Peter K Dearden; Shu-Biao Wu; Jane Wilson-Wheeler; Dianne M Sharp; Patricia Lundon-Treweek; Gillian M Clover; Jean-Charles Hoda; Jörg Striessnig; Rainer Marksteiner; Steffen Hering; Marion A Maw
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-16       Impact factor: 11.205

Review 10.  Pore stability and gating in voltage-activated calcium channels.

Authors:  Steffen Hering; Stansilav Beyl; Anna Stary; Michaela Kudrnac; Annette Hohaus; H Robert Guy; Eugen Timin
Journal:  Channels (Austin)       Date:  2008-03-14       Impact factor: 2.581

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.